Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heinzelmann

Showing results (611-620 of 663) with videos related to

Pageof 67
Sort By:
EMBO Molecular Medicine|April 21, 2018
Cholesterol metabolism promotes B-cell positioning during immune pathogenesis of chronic obstructive pulmonary diseaseJie Jia, Thomas M Conlon, Rim Sj Sarker, et al.
Journal for Immunotherapy of Cancer|July 4, 2020
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancerMarta Trüb, Franziska Uhlenbrock, Christina Claus, et al.
Bulletin Du Cancer|March 26, 2023
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancerPhilipp Harter, Gerhard Bogner, Luis Chiva, et al.
Cancers|November 25, 2023
Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors-Results of Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG SurveyHannah Woopen, Maren Keller, Dario Zocholl, et al.
Molecular Psychiatry|February 14, 2023
MYT1L haploinsufficiency in human neurons and mice causes autism-associated phenotypes that can be reversed by genetic and pharmacologic interventionBettina Weigel, Jana F Tegethoff, Sarah D Grieder, et al.
Journal for Immunotherapy of Cancer|November 17, 2024
Inhibition of Cbl-b restores effector functions of human intratumoral NK cellsSofia Tundo, Marcel Trefny, Andrijana Rodić, et al.
Cell Reports|August 17, 2022
Glycosphingolipids are mediators of cancer plasticity through independent signaling pathwaysCécile Cumin, Yen-Lin Huang, Charlotte Rossdam, et al.
The Journal of Clinical Investigation|August 22, 2018
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cellsMichal A Stanczak, Shoib S Siddiqui, Marcel P Trefny, et al.
Gynecologic Oncology|October 13, 2019
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancersS Intidhar Labidi-Galy, Thibault de La Motte Rouge, Olfa Derbel, et al.
Cancer Research|August 17, 2012
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicinPrue A Cowin, Joshy George, Sian Fereday, et al.
Pageof 67

Showing results (611-620 of 663) with videos related to

Sort By:
Pageof 67
EMBO Molecular Medicine|April 21, 2018
Cholesterol metabolism promotes B-cell positioning during immune pathogenesis of chronic obstructive pulmonary diseaseJie Jia, Thomas M Conlon, Rim Sj Sarker, et al.
Journal for Immunotherapy of Cancer|July 4, 2020
Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancerMarta Trüb, Franziska Uhlenbrock, Christina Claus, et al.
Bulletin Du Cancer|March 26, 2023
Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancerPhilipp Harter, Gerhard Bogner, Luis Chiva, et al.
Cancers|November 25, 2023
Side Effects from Cancer Therapies and Perspective of 1044 Long-Term Ovarian Cancer Survivors-Results of Expression VI-Carolin Meets HANNA-Holistic Analysis of Long-Term Survival with Ovarian Cancer: The International NOGGO, ENGOT, and GCIG SurveyHannah Woopen, Maren Keller, Dario Zocholl, et al.
Molecular Psychiatry|February 14, 2023
MYT1L haploinsufficiency in human neurons and mice causes autism-associated phenotypes that can be reversed by genetic and pharmacologic interventionBettina Weigel, Jana F Tegethoff, Sarah D Grieder, et al.
Journal for Immunotherapy of Cancer|November 17, 2024
Inhibition of Cbl-b restores effector functions of human intratumoral NK cellsSofia Tundo, Marcel Trefny, Andrijana Rodić, et al.
Cell Reports|August 17, 2022
Glycosphingolipids are mediators of cancer plasticity through independent signaling pathwaysCécile Cumin, Yen-Lin Huang, Charlotte Rossdam, et al.
The Journal of Clinical Investigation|August 22, 2018
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cellsMichal A Stanczak, Shoib S Siddiqui, Marcel P Trefny, et al.
Gynecologic Oncology|October 13, 2019
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancersS Intidhar Labidi-Galy, Thibault de La Motte Rouge, Olfa Derbel, et al.
Cancer Research|August 17, 2012
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicinPrue A Cowin, Joshy George, Sian Fereday, et al.
Pageof 67